Managing Pain in the Terminally Ill
Download in electronic PDF format for $75
Abstract: The purpose of this article is to present a case that illustrates the basics of pain management. The author is a palliative-care specialist and hospice medical director. The case involves a 57-year-old man who was diagnosed with large-cell carcinoma of the lung. The patient was eventually treated with a compounded suppository of haloperidol + metoclopramide + dexamethasone until the final stages of his illness, when he was switched to hydromorphone given as a continuous subcutaneous infusion. His expiration was peaceful. The author discusses the principles of pain management applied to this case. A table provides information regarding opiate equivalents. The author concludes that barriers to the use of modern opiates and synthetic opioids derived from the poppy must be addressed at an international level. The expertise of the compounding pharmacist is needed to bring drugs together in formulations previously unavailable and also in allowing novel and innovative delivery systems to be explored.
Related Keywords:
Hospice, Hydromorphone, Kadian, Oxycodone, Palliative, Percodan
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Managing Pain in the Terminally Ill
Williams Clifford L
|
Mar/Apr 1998
Pg. 111-114
|
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
McNulty John P, Muller George
|
May/Jun 2014
Pg. 190-200
|
Ketamine for Pain in Hospice Patients
Wood Robert M
|
Jul/Aug 2000
Pg. 253-254
|
Managing Pain with Transdermal Ketoprofen
Williams KaCee D
|
May/Jun 2010
Pg. 204-206
|
Principles of Pediatric Palliative Care and Pain Control
Peralta Alexander Jr
|
Jan/Feb 2007
Pg. 10-15
|
Update on Managing Neuropathic Pain
McNulty Jack P, Muller George
|
May/Jun 2009
Pg. 182-190
|
Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Christiansen Joel, White Lyndell
|
Jul/Aug 2010
Pg. 310-314
|
Hospice from a Compounding Pharmacist's Perspective
Jones Marty
|
Mar/Apr 2006
Pg. 89-93
|
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
|
May/Jun 2010
Pg. 182-192
|
Topical Medications for Orofacial Neuropathic Pain
Bramwell Bethany L
|
May/Jun 2010
Pg. 200-203
|
Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution
Allen Loyd V Jr
|
Mar/Apr 2015
Pg. 148
|
Hospice and Compounding Pharmacy: Once Inseperable
Williams LaVonn A
|
Jan/Feb 2008
Pg. 28-37
|
Hospice and the Role of the Compounding Pharmacist
Carling Maureen A
|
Jul/Aug 2000
Pg. 246-249
|
Physical and Chemical Stability of Hydromorphone Hydrochloride 1.5- and 80-mg/mL Packaged in Plastic Syringes
Trissel Lawrence A, Xu Quanyun A, Pham Lien
|
Jan/Feb 2002
Pg. 74-76
|
Palliative Care and Compounding for Household Pets
Gaskins Jessica L
|
Nov/Dec 2012
Pg. 452-455
|
Compounded Oral Ketamine for Severe Depression, Anxiety, and Pain in a Hospice Patient with End-stage Chronic Obstructive Pulmonary Disease, Cardiopulmonary Failure, and Severe Renal Insufficiency: A Case Report
McNulty Jack P, Hahn Kristian
|
Sep/Oct 2012
Pg. 364-368
|
In Vitro Evaluation of Extemporaneously Compounded Slow-Release Capsules Containing Morphine Sulfate or Oxycodone Hydrochloride
Glowiak Dana L, Green Julie L, Bowman Bill J
|
Mar/Apr 2005
Pg. 157-164
|
Topical Treatment of Neuropathic Pain
Vadaurri Vince
|
May/Jun 2008
Pg. 182-190
|
Hospice Symptom Relief Kit: An Update
Petrin Ronald L
|
Jul/Aug 2006
Pg. 288-290
|
Physical Compatibility of Medications Used in Critically Ill Patients with Balanced Fluid Solutions
Wilder Alyson G, Foushee Jaime A, Fox Laura M, Navalle Jordan, Wright Adrienne M, Greer Megan A
|
May/Jun 2020
Pg. 238-241
|
Return to Top |